1Larsen R,Daves TF,Hay LD,et al. Wilson textbook of endocrinology. 9th ed. Harcourt Asia:WB Sanders,2001. 442-447
2Kuo S, Huang W, Hu C,et al. Effects of T4 administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy. Eur J Endocrinol, 1994,131(2):125-130
3Hashizume K, Ichikawa K, Sakurai A, et al. Administration of T4 in Treated Graves disease: effects on the level of antibodies to thyroid stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med,324(8) :947-953
4Rittmaster RS, Abbot EC, Diuglas R, et al. Effect of methimazole,with or without L-Thyroxine, on remission rates in graves disease. JClin Endocrinol Metab, 1998,83(3):814-818
5Lucas A, Salinas I, Rius F, et al. Medical therapy of graves disease:Dose thyroxine prevent recurrence of hyperthyroidism? J Clin Endocrinol Metab,1997,82(8) :2410-2413
2Hershman JM. Dose thyroxine therapy prevent recurrence of Graves'hyperthyroidism? J Clin Endocrinol Metab, 1995,80:1 479- 1 480.
3Hashizume K, Ichikawa K, Sakurai A, et al. Administration of thyroxine in treated Graves'disease effect on the level of antibodies to thyroid - stumulating hormone receptor and on therisk of recurrence of hyperthyroidian. N Engl J Med, 1991,324:947 - 953.
4Glmoer D, Denayer P, Bex M. Effect of L - thyroixine administration, TSH receptor antibodies and smoking on the risk of recurrence in Graves'hyperthyroidism treated with antihyroid drugs a double - blinded prospective randomized. Study Eur J Endocrinol,2001,144:475 - 483.
5Toft A. Thyroixine suppression therapy in Graves disease. Baillieves Clin Endocrinol Metab, 1997,11(3) :537 - 548.
6Ladenson PW. Treatments for Grave's disease: Letting the thyroid rest.(Editorial) .N Engl J Med, 1991,324:989- 990.
